Literature DB >> 6432117

Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome.

P C Tai, M E Holt, P Denny, A R Gibbs, B D Williams, C J Spry.   

Abstract

Biopsy specimens and tissues obtained at necropsy from two women who died after developing the Churg-Strauss syndrome were analysed to see whether granulomas in these patients contained activated eosinophils or secreted eosinophil cationic proteins, or both. Immunocytochemical studies with monoclonal antibody EG2 showed large amounts of eosinophil cationic protein and eosinophil protein-X (which are toxic for heart cells and other tissues) in the granulomas. Many activated and degranulating eosinophils were seen to be migrating from the blood into these areas. Eosinophils may play a central part in the development of lesions in the heart and other tissues in the Churg-Strauss syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432117      PMCID: PMC1442412          DOI: 10.1136/bmj.289.6442.400

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

Authors:  J CHURG; L STRAUSS
Journal:  Am J Pathol       Date:  1951 Mar-Apr       Impact factor: 4.307

2.  Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein.

Authors:  P C Tai; C J Spry; C Peterson; P Venge; I Olsson
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

3.  Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A G Davison; P J Thompson; J Davies; B Corrin; M Turner-Warwick
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

4.  Cardiovascular features of 11 patients with eosinophilic endomyocardial disease.

Authors:  J Davies; C J Spry; R Sapsford; E G Olsen; G de Perez; C M Oakley; J F Goodwin
Journal:  Q J Med       Date:  1983

5.  Toxic effects of human eosinophil products on isolated rat heart cells in vitro.

Authors:  P C Tai; D J Hayes; J B Clark; C J Spry
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

6.  Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma.

Authors:  W V Filley; K E Holley; G M Kephart; G J Gleich
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

7.  Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro.

Authors:  D J McLaren; J R McKean; I Olsson; P Venges; A B Kay
Journal:  Parasite Immunol       Date:  1981       Impact factor: 2.280

8.  Churg-Strauss syndrome. Development of cardiomyopathy during corticosteroid treatment.

Authors:  M M Wishnick; Q Valensi; E F Doyle; A Balian; N B Genieser; G Chrousos
Journal:  Am J Dis Child       Date:  1982-04

9.  Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome.

Authors:  M S Peters; A L Schroeter; G J Gleich
Journal:  Br J Dermatol       Date:  1983-08       Impact factor: 9.302

10.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

Authors:  I Winqvist; T Olofsson; I Olsson; A M Persson; T Hallberg
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

View more
  18 in total

1.  Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Neurology of the vasculitides and connective tissue diseases.

Authors:  P M Moore; B Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

Review 3.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

4.  Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.

Authors:  Y Raab; K Fredens; B Gerdin; R Hällgren
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.

Authors:  M K Samoszuk; V Nguyen; I Gluzman; J H Pham
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 6.  The aetiology and pathogenesis of major systemic vasculitides.

Authors:  C O Savage; Y C Ng
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

7.  Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas.

Authors:  M K Samoszuk; B N Nathwani; R J Lukes
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

Review 8.  Vasculitis in childhood.

Authors:  I Roberti; L Reisman; J Churg
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Churg-Strauss vasculitis and ascaris infection.

Authors:  A Chauhan; D G Scott; J Neuberger; J S Gaston; P A Bacon
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

10.  Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

Authors:  R Hällgren; B Gudbjörnsson; E Larsson; K Fredens
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.